Picture of Q Linea AB logo

QLINEA Q Linea AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Q-Linea Presents Positive Interim Data From European Trial

March 31 (Reuters) - Q linea AB  QLINEA.ST :
    * Q-LINEA PRESENTS POSITIVE INTERIM DATA FROM EUROPEAN TRIAL
    * TODAY ANNOUNCED VERY GOOD INTERIM RESULTS FROM PIVOTAL
EUROPEAN
TRIAL FOR ANTIBIOTIC SUSCEPTIBILITY SYSTEM ASTAR®
    * EA WAS OVER 94 PERCENT, CA OVER 97 PERCENT AND OVERALL
REPRODUCIBILITY OVER 99 PERCENT.
    * REPRODUCIBILITY WAS VERY HIGH AND EXCEEDED 99 PERCENT

Source text for Eikon:  ID:nMFN1dDsWc 
Further company coverage:  QLINEA.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

Recent news on Q Linea AB

See all news